Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

350 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The distinctive biology of cancer in adolescents and young adults.
Bleyer A, Barr R, Hayes-Lattin B, Thomas D, Ellis C, Anderson B; Biology and Clinical Trials Subgroups of the US National Cancer Institute Progress Review Group in Adolescent and Young Adult Oncology. Bleyer A, et al. Nat Rev Cancer. 2008 Apr;8(4):288-98. doi: 10.1038/nrc2349. Nat Rev Cancer. 2008. PMID: 18354417 Review.
Colorectal cancer in young adults.
Zbuk K, Sidebotham EL, Bleyer A, La Quaglia MP. Zbuk K, et al. Among authors: bleyer a. Semin Oncol. 2009 Oct;36(5):439-50. doi: 10.1053/j.seminoncol.2009.07.008. Semin Oncol. 2009. PMID: 19835739 Review.
Benefits and adverse events in younger versus older patients receiving adjuvant chemotherapy for colon cancer: findings from the Adjuvant Colon Cancer Endpoints data set.
Hubbard J, Thomas DM, Yothers G, Green E, Blanke C, O'Connell MJ, Labianca R, Shi Q, Bleyer A, de Gramont A, Sargent D. Hubbard J, et al. Among authors: bleyer a. J Clin Oncol. 2012 Jul 1;30(19):2334-9. doi: 10.1200/JCO.2011.41.1975. Epub 2012 May 21. J Clin Oncol. 2012. PMID: 22614981 Free PMC article.
Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysis.
Collins M, Wilhelm M, Conyers R, Herschtal A, Whelan J, Bielack S, Kager L, Kühne T, Sydes M, Gelderblom H, Ferrari S, Picci P, Smeland S, Eriksson M, Petrilli AS, Bleyer A, Thomas DM. Collins M, et al. Among authors: bleyer a. J Clin Oncol. 2013 Jun 20;31(18):2303-12. doi: 10.1200/JCO.2012.43.8598. Epub 2013 May 13. J Clin Oncol. 2013. PMID: 23669227
Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen--a new intensive therapy protocol: a report from the Childrens Cancer Study Group.
Steinherz PG, Gaynon P, Miller DR, Reaman G, Bleyer A, Finklestein J, Evans RG, Meyers P, Steinherz LJ, Sather H, et al. Steinherz PG, et al. Among authors: bleyer a. J Clin Oncol. 1986 May;4(5):744-52. doi: 10.1200/JCO.1986.4.5.744. J Clin Oncol. 1986. PMID: 3517244 Clinical Trial.
350 results